Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics, Inc. Common Stock (NMRA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NMRA · as of Jun 8, 2026
Key Statistics
Explore Neumora Therapeutics, Inc. Common Stock Data
nmra stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 66.7%
The NMRA analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $7.00, representing +333.14% upside from the current price of $1.62.
Competitors & Peers
nmra competitorsNMRA
ADCT
ALMS
AUTL
BCYC
FDMTStock Performance
Full HistoryAbout Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The…
what is neumora therapeutics, inc. common stock · nmra stock overview · neumora therapeutics, inc. common stock company profile · who is neumora therapeutics, inc. common stock ceo · nmra NASDAQ · neumora therapeutics, inc. common stock headquarters · neumora therapeutics, inc. common stock business segments
About Stock Overview & Key Data
Neumora Therapeutics, Inc. Common Stock (NMRA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 15, 2023. As of the latest trading session, NMRA stock price is $1.62, with a market capitalization of $299.2M. The stock has returned +48.17% over the past 12 months and -9.78% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Neumora Therapeutics, Inc. Common Stock stock is Buy, with an average 12-month price target of $7.00. In fiscal year 2025, Neumora Therapeutics, Inc. Common Stock reported revenue of — and net income of -$236.9M. For detailed data — including Neumora Therapeutics, Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Neumora Therapeutics, Inc. Common Stock (NMRA) stock price is $1.62. The stock is traded on NASDAQ under the ticker symbol NMRA. The 52-week range is $0.72 – $3.65.